Related Experiment Video
Updated: Jan 24, 2026

A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening
Published on: May 12, 2017
A promiscuous kinase inhibitor reveals secrets to cancer cell survival
1Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland 21201.
Abstract:
Deregulated kinase signaling networks drive the growth and survival of many cancer cells. However, the genetic complexity and rapidly evolving nature of most cancer cells create challenges when identifying the most relevant kinases to inhibit to achieve optimal therapeutic benefits. A new strategy that takes advantage of a well-characterized multitargeted kinase inhibitor describes a nongenetic approach to tease out key kinases that promote proliferation of specific cancer cell types.
Insights
Identifying key cancer-driving kinases is challenging due to tumor complexity. A novel nongenetic strategy using a multitargeted kinase inhibitor helps pinpoint critical kinases for cancer cell proliferation, aiding therapeutic development.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Kinase signaling pathways are crucial for cancer cell growth and survival.
- Cancer cells exhibit genetic complexity and rapid evolution, complicating targeted therapy.
- Identifying specific kinases driving cancer proliferation is essential for effective treatment.
Purpose of the Study:
- To develop a nongenetic strategy for identifying key kinases in cancer cell proliferation.
- To leverage a multitargeted kinase inhibitor to overcome challenges in kinase identification.
- To provide a method for pinpointing kinases essential for specific cancer cell types.
Main Methods:
- Utilized a well-characterized multitargeted kinase inhibitor.
- Employed a nongenetic approach to assess kinase roles.
- Focused on identifying kinases promoting proliferation in distinct cancer cell types.
Main Results:
- Successfully demonstrated a nongenetic method for kinase identification.
- The strategy effectively distinguished key kinases driving proliferation.
- Provided insights into kinase dependencies in specific cancer contexts.
Conclusions:
- A novel nongenetic strategy can effectively identify critical kinases in cancer.
- This approach aids in understanding kinase-driven cancer cell proliferation.
- The method offers a promising avenue for developing targeted cancer therapies.
Related Concept Videos
Cancer Survival Analysis
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Cells and Secretions of the Pancreas
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Survival Tree
Building a Survival Tree
Constructing a...

